Robot/Laparoscopic-Assisted Transanal Transection Duhamel Versus Modified Soave Pull-Through for TCA

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-14
SponsorZunyi Medical College

About this trial

Total colonic Hirschsprung disease (TCA) is the most severe form of Hirschsprung disease and is commonly managed with neonatal enterostomy followed by delayed definitive pull-through. Despite widespread use, the optimal reconstructive procedure for TCA remains uncertain. The Duhamel and modified Soave pull-through procedures are the two most frequently adopted techniques, each with distinct theoretical advantages and limitations regarding bowel function, enterocolitis risk, and anorectal physiology. With the increasing application of minimally invasive and robot-assisted surgery, both procedures have been further refined; however, robust comparative evidence, particularly for total colonic disease, is lacking. To date, no multicenter study has provided a detailed comparison of postoperative functional outcomes and Hirschsprung-associated enterocolitis between transanal transection Duhamel and modified Soave procedures. This multicenter study compares robot-assisted transanal transection Duhamel and modified Soave pull-through in patients with pathologically confirmed TCA after neonatal enterostomy, focusing on postoperative bowel function and enterocolitis incidence.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Definitive diagnosis of total colonic Hirschsprung disease confirmed by pathology from biopsy at neonatal enterostomy, consistent with total colonic aganglionosis.

Two-stage surgical strategy: neonatal enterostomy performed first, followed by definitive pull-through as a second-stage procedure.

Robot-assisted transanal transection Duhamel, orModified Soave pull-through (minimally invasive abdominal phase allowed).

Availability for follow-up assessments and outcomes collection per protocol.

Disqualifiers

Trisomy 21 (Down syndrome).

Definitive surgery performed by open laparotomy approach or Swenson procedure.

One-stage primary pull-through without neonatal enterostomy (single-stage definitive management).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transanal Transection Duhamel operation

    Procedure/Surgery

    The modified Duhamel procedure was performed using a transanal external rectal transection technique. Following mobilization of the ganglionated colon, the distal rectum was transected externally through the anal canal, expanding pelvic operative space and improving exposure compared with conventional pelvic transection. A retrorectal channel was created, and the colon was pulled through posterior to the native rectum. Residual rectal septum (spur) was eliminated using a transanal external compression technique, enabling a wide side-to-side colorectal or coloanal anastomosis. The anterior rectal wall was preserved, maintaining rectal sensory structures and avoiding circumferential endorectal dissection as used in Soave procedures. This approach was intended to optimize anastomotic configuration and postoperative bowel function.

  • Modified Soave Pull-Through

    Procedure/Surgery

    The modified Soave procedure was performed as a definitive pull-through following neonatal enterostomy. At approximately 1 year of age or older, patients underwent minimally invasive colectomy using a robotic-assisted or laparoscopic approach. The entire aganglionic colon was resected, and an endorectal pull-through was performed. The terminal ileum was delivered through the rectal cuff and anastomosed to the anal canal to restore intestinal continuity. This technique eliminates the aganglionic colorectal segment and avoids creation of a retrorectal pouch. Perioperative management and postoperative care were standardized across participating centers according to the study protocol.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Transanal Transection Duhamel Pull-Through for total colonic aganglionosisExperimental treatment 1 intervention
Group B: Modified Soave Pull-Through for total colonic aganglionosisActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative bowel function

Defecation function will be evaluated using the Rintala scoring, which comprises seven domains: bowel control, awareness of the urge to defecate, defecation frequency, stool consistency, fecal soiling, constipation, and social functioning. A total score of 17-20 points is classified as excellent, 12-16 points as good, 9-11 points as fair, and ≤8 points as poor.24 months after definitive pull-through .

Time frame
From enrollment to the end of treatment at 24 months
2

Hirschsprung-associated enterocolitis (HAEC) incidence

HAEC diagnosed using a standardized criterion ( prespecified clinical criteria) and recorded as: cumulative incidence, number of episodes, episodes requiring hospitalization/IV antibiotics.

Time frame
From enrollment to the end of treatment at 24 months

Secondary outcomes

1

Operative time

During definitive pull-through operation

Time frame
During surgery
2

Intraoperative blood loss (ml)

Time frame
During surgery
3

Postoperative length of stay (days)

Time frame
From enrollment to the end of treatment at 24 months
4

postoperative complications

Overall postoperative complications within 30 days and within 12 months: anastomotic stricture, postoperative bleeding, perianal dermatitis, other prespecified surgical complications (ileus, pelvic abscess, reoperation)

Time frame
within 30 days and within 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Zunyi Medical College

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Collaborator

The First Affiliated Hospital of Zhengzhou University

Collaborator

Shenzhen Maternity & Child Healthcare Hospital

Collaborator

The Affiliated Hospital of Binzhou Medical College

Collaborator

Guizhou Provincial People's Hospital

Collaborator

This trial is not recruiting at the moment. You can still explore other options: